Advocacy

Posted By: Lyly Luhachack, PhD, Policy & Advocacy Specialist, ASHG April 22, 2021, marked the first-ever ASHG Capitol Hill Day. The Government and Public Advocacy Committee (GPAC), ASHG President Gail Jarvik, MD, PhD, Dana Crawford, PhD, Diversity, Equity, and Inclusion Task Force (DEITF) Chair, and leaders of the Career Development Committee (CDC) met, virtually, with... Read More

Published: Thursday, April 22, 2021, 4:30 p.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – Earlier today, the American Society of Human Genetics (ASHG) hosted its first ever Hill Day. Due to the continued impacts of the COVID-19 pandemic, Hill Day 2021 was hosted virtually, making advocating for geneticists more accessible than ever.... Read More

The Government and Public Advocacy Committee (GPAC) met in 2020 to create its action plan. The resulting plan enables the Society to consistently convey the benefits of genetics and genomics research to policymakers and other influencers, and conveys the need for policies supportive of research and the appropriate use of genetics and genomics knowledge. The... Read More

ASHG supports the nomination of Eric Lander, PhD, to lead the Office of Science and Technology Policy (OSTP).  The announcement of the new team at the dawn of President Biden’s presidency, and elevating the Director of OSTP to a Cabinet position, is a positive sign that science, and scientists, will have a core role in... Read More

The first few weeks of 2021 have brought numerous changes to the federal policy landscape, including the beginning of the new Biden Administration, a new Congress with a Democratic majority in both the Senate and the House of Representatives, and the deadly January 6 attack on the U.S. Capitol and its fallout.  While these events... Read More